BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  IRRAS AB (PUBL) Interim Report January-September 2018

  Preparation for US launch of IRRAflow® ongoing, CE mark catheter re-certification now expected at YE 2018

  November 8, 2018

   · 

  4 min read
• Drug Development

  NextCure to Present Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

  NextCure, Inc. today announced that preclinical data supporting the development of its lead drug candidate, NC318, will be presented in a poster session at the Society for Immunotherapy of Cancer 33rd Annual Meeting being held November 7th – 11th 2018 in Washington, D.C.

  November 8, 2018

   · 

  2 min read
• Business

  Triple-S Management Corporation Reports Third Quarter 2018 Results

  Triple-S Management Corporation today announced its third quarter 2018 results.

  November 8, 2018

   · 

  25 min read
• Business

  Endo Reports Third-Quarter 2018 Financial Results

  Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million

  November 8, 2018

   · 

  35 min read
• Business

  Berry Genomics and Prenetics Establish JV to Enter China’s Consumer Genetics Market

  Global genetics testing market expected to be worth USD 50-billion per annum by 20261

  November 8, 2018

   · 

  3 min read
• Business

  American Family Care Honors Veterans with Free Flu Shots

  Health Care Leader to Serve Those Who Have Served Our Country

  November 8, 2018

   · 

  3 min read
• Drug Development

  Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist

  Oral Formulation Clinical Data Currently Anticipated by Year End

  November 8, 2018

   · 

  5 min read
• Orexo to Host a Capital Markets Day on Dec. 6 With the US President´s Former Advisor as Keynote Speaker

  Orexo will provide an update on the Company’s strategy for growth, market trends and position and its increased focus on R&D, including new innovative formulation technologies.

  November 8, 2018

   · 

  2 min read
• Business

  Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results

  INVELTYS™ Launch on Track for Early 2019

  November 8, 2018

   · 

  12 min read
• Business

  ProCredEx Announces Launch of Partner Program with National Government Services, Spectrum Health System, WellCare, Accenture, and The Hardenbergh Group

  Industry Leaders Focus on Resolving Administrative Burden in Healthcare Credentialing Using Blockchain-Driven Technology

  November 8, 2018

   · 

  5 min read